| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $371.2M | — |
| R&D Expense | $387.3M | -16.1% |
| SG&A Expense | $76.2M | -25.7% |
| Operating Income | -$222.5M | +66.9% |
| Pre-tax Income | -$150.7M | +76.8% |
| Income Tax | $2.9M | +988.6% |
| Net Income | -$153.6M | +76.4% |
| EPS (Basic) | -$1.94 | +76.8% |
| EPS (Diluted) | -$1.94 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $389.5M | +83.8% |
| Short-term Investments | $1.30B | -18.7% |
| Accounts Receivable | $200.0M | — |
| Current Assets | $1.91B | +3.0% |
| Total Assets | $2.23B | -0.6% |
| Current Liabilities | $108.8M | -10.2% |
| Total Liabilities | $346.8M | -5.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$260.4M | +47.5% |
| Capital Expenditures | $9.5M | -74.5% |
| Investing Cash Flow | $374.6M | +244.8% |
| Financing Cash Flow | $62.7M | +62.4% |
| Free Cash Flow | -$269.8M | +49.4% |
| +76.8% |
| Stockholders' Equity |
| $1.88B |
| +0.4% |